Community oncologists face unique challenges in engaging patients in clinical trials due to time constraints, administrative burdens, and limited resources. In contrast to academic centers, these physicians juggle a variety of malignancies, making it difficult to stay updated on trial opportunities for specific tumor types. Without the necessary support, many clinicians prioritize standard treatments over enrolling patients in trials. Dr.
Nina Balanchivadze emphasizes the importance of inclusive research at the community level to address these barriers and ensure equitable access to cutting-edge therapies. Understanding physician, system, and patient-related obstacles is crucial for developing practical solutions. Infrastructure limitations, geographic distance from trial sites, lack of patient awareness, and misconceptions about trials all contribute to low participation rates. By recognizing and addressing these challenges, we can empower community oncologists to provide their patients with the opportunity to benefit from innovative research initiatives.
Read more on targetedonc.com